Efficacy of Gaviscon-Advance ® in Suppressing Post-supper Acid-pocket and Night-time Acid-reflux in Obese Participants
Conditions: Gastroesophageal Reflux Disease; Acid Reflux; Obesity Interventions: Drug: Alginate-antacid group; Drug: Non antacid alginate group Sponsor: University of Science Malaysia Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acid Reflux | Eating Disorders & Weight Management | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Malaysia Health | Obesity | Research